SE409709B - Forfarande for framstellning av 1,4-bensodiozepinderivat - Google Patents

Forfarande for framstellning av 1,4-bensodiozepinderivat

Info

Publication number
SE409709B
SE409709B SE7306128A SE7306128A SE409709B SE 409709 B SE409709 B SE 409709B SE 7306128 A SE7306128 A SE 7306128A SE 7306128 A SE7306128 A SE 7306128A SE 409709 B SE409709 B SE 409709B
Authority
SE
Sweden
Prior art keywords
group
phenyl
derivative
methyl
hydroxy
Prior art date
Application number
SE7306128A
Other languages
English (en)
Swedish (sv)
Inventor
W Milkowski
R Budden
S Funke
R Huschens
H-G Liepmann
W Stuhmer
H Zeugner
Original Assignee
Kali Chemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Ag filed Critical Kali Chemie Ag
Publication of SE409709B publication Critical patent/SE409709B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D245/06—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE7306128A 1972-05-03 1973-05-02 Forfarande for framstellning av 1,4-bensodiozepinderivat SE409709B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2221558A DE2221558C2 (de) 1972-05-03 1972-05-03 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepine und ihre Säureadditionssalze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
SE409709B true SE409709B (sv) 1979-09-03

Family

ID=5843904

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7306128A SE409709B (sv) 1972-05-03 1973-05-02 Forfarande for framstellning av 1,4-bensodiozepinderivat
SE7614681A SE7614681L (sv) 1972-05-03 1976-12-29 Sett att framstella nya bensodiazepinderivat
SE7614680A SE422460B (sv) 1972-05-03 1976-12-29 1,5-bensodiazocinderivat till anvendning som mellanprodukt for framstellning av 1,4-bensodiazepiner samt sett for framstellning derav

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE7614681A SE7614681L (sv) 1972-05-03 1976-12-29 Sett att framstella nya bensodiazepinderivat
SE7614680A SE422460B (sv) 1972-05-03 1976-12-29 1,5-bensodiazocinderivat till anvendning som mellanprodukt for framstellning av 1,4-bensodiazepiner samt sett for framstellning derav

Country Status (18)

Country Link
US (6) US3998809A (no)
JP (3) JPS5541231B2 (no)
AT (3) AT327927B (no)
BE (1) BE799001A (no)
CA (3) CA984388A (no)
CH (5) CH611609A5 (no)
DD (1) DD105222A5 (no)
DE (3) DE2265370C2 (no)
DK (3) DK147050C (no)
ES (1) ES414279A1 (no)
FR (3) FR2183735B1 (no)
GB (3) GB1429666A (no)
IL (5) IL42158A (no)
NL (1) NL179111C (no)
NO (6) NO142866C (no)
SE (3) SE409709B (no)
SU (2) SU526290A3 (no)
ZA (1) ZA733013B (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2265370C2 (de) * 1972-05-03 1982-12-02 Kali-Chemie Ag, 3000 Hannover 6-Phenyl-1,2,3,4-tetrahydro-1,5-benzodiazocinderivate
US4244869A (en) * 1972-05-03 1981-01-13 Kali-Chemie A.G. Benzodiazepine derivatives and process of making them
DE2520937C3 (de) * 1975-05-10 1978-10-12 Kali-Chemie Ag, 3000 Hannover 7-Brom-1 -methyl^-alkoxymethyl-S-(2-halogenphenyl)-lH-23-dihydro-l,4benzodiazepinderivate, deren Säureadditionssalze und pharmazeutische Präparate
DE2720908A1 (de) * 1977-05-10 1978-11-23 Kali Chemie Pharma Gmbh Arzneimittel mit ulkustherapeutischem effekt
ES469020A1 (es) * 1977-05-10 1979-09-01 Kali Chemie Pharma Gmbh Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos
DE2720968C2 (de) * 1977-05-10 1986-05-07 Kali-Chemie Pharma Gmbh, 3000 Hannover N↓1↓-Acyl-2-hydroxy-1,3-diaminopropane und Arzneimittel
US4123430A (en) * 1977-11-10 1978-10-31 G. D. Searle & Co. 2-Aryl-4-(1-piperazinyl)-3H-1,5-benzodiazepines
DE2754112A1 (de) * 1977-12-05 1979-06-13 Kali Chemie Pharma Gmbh 1,4-benzodiazepinderivate, ihre salze und diese verbindungen enthaltende arzneipraeparate
DE2810349A1 (de) * 1978-03-10 1979-09-20 Kali Chemie Pharma Gmbh Verfahren zur herstellung von 3-hydroxy-6-phenyl-1,2,3,4-tetrahydro- 1,5-benzodiazocinen
US4368157A (en) * 1978-05-15 1983-01-11 Hoffmann-La Roche Inc. Intermediates to produce imidazodiazepines
US4368159A (en) * 1978-05-15 1983-01-11 Hoffmann-La Roche Inc. Intermediates to produce imidazodiazepines
US4371468A (en) * 1978-05-15 1983-02-01 Hoffmann-La Roche Inc. Intermediates to produce imidazodiazepines
US4368158A (en) * 1978-05-15 1983-01-11 Hoffmann-La Roche Inc. Intermediates to produce imidazodiazepines
DE2827801A1 (de) * 1978-06-24 1980-01-10 Kali Chemie Pharma Gmbh Neue n tief 1 -benzoyl-n tief 2 -phenyl-1,3-diaminopropan-2-ole, verfahren zu deren herstellung und arzneimittel
DE2835708A1 (de) 1978-08-16 1980-03-06 Kali Chemie Pharma Gmbh Neue eckige klammer auf 1,2 eckige klammer zu-anellierte 7-phenyl-1,4-benzodiazepinderivate, verfahren zu deren herstellung und arzneimittel
JPS5775313A (en) * 1980-10-30 1982-05-11 Fanuc Ltd Numerical controller of machine tool
DE3048264A1 (de) * 1980-12-20 1982-09-09 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3124013A1 (de) * 1981-06-19 1982-12-30 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3138769A1 (de) * 1981-09-30 1983-04-14 Kali-Chemie Pharma Gmbh, 3000 Hannover 7-brom-5-(2-halogenphenyl)-1h-2,3-dihydro-1,4- benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3151597A1 (de) * 1981-12-28 1983-07-07 Kali-Chemie Pharma Gmbh, 3000 Hannover (1,2)-anellierte 1,4-benzodiazepin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3221402A1 (de) * 1982-06-05 1983-12-08 Kali-Chemie Pharma Gmbh, 3000 Hannover 5-phenyl-1,4-benzodiazepine enthaltende analgetisch wirksame pharmazeutische zubereitungen
US4493168A (en) * 1983-06-16 1985-01-15 Coburn Optical Industries, Inc. Calibration gauge for computer-controlled lens generator, or the like
US4786449A (en) * 1983-12-28 1988-11-22 Clowny Corporation Method for manufacture of multi-color marking implements
US4602886A (en) * 1983-12-28 1986-07-29 Smit Adrianus J Multi-color marking implement
US4684646A (en) * 1984-06-26 1987-08-04 Merck & Co., Inc. 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagonists
EP0170024A3 (en) * 1984-06-26 1990-01-31 Merck & Co. Inc. Use of 2-acylaminomethyl-1,4-benzodiazepine derivatives for the production of pharmaceutical compositions and process for the preparation for pharmaceutical compositions
US4724237A (en) * 1984-06-26 1988-02-09 Merck & Co., Inc. 2-substituted-aminomethyl-1,4-benzodiazepines
JPS61114933A (ja) * 1984-11-12 1986-06-02 Tokyo Electric Co Ltd 事務機の給紙装置
JPH0618794Y2 (ja) * 1987-06-17 1994-05-18 株式会社スギノマシン ウォータジェット加工機
JPH0418564Y2 (no) * 1988-01-08 1992-04-24
US5856497A (en) * 1995-12-11 1999-01-05 Boehringer Ingelheim Pharmaceuticals, Inc. Asymmetric synthesis of α-cycloalkylalkyl substituted methanamines
US5670640A (en) * 1996-02-02 1997-09-23 Hoffmann-La Roche Inc. Process for the manufacture of imidazodiazepine derivatives
EP0918773A1 (en) * 1996-07-01 1999-06-02 PHARMACIA & UPJOHN COMPANY Process for the production of 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo 1,5-a]benzodiazepine
US6818607B1 (en) * 1999-08-27 2004-11-16 Procter & Gamble Company Bleach boosting components, compositions and laundry methods
CN1384867A (zh) 1999-08-27 2002-12-11 宝洁公司 稳定性提高的配制组分、使用该组分的组合物和洗衣方法
US6821935B1 (en) 1999-08-27 2004-11-23 Procter & Gamble Company Color safe laundry methods employing zwitterionic formulation components
US7109156B1 (en) 1999-08-27 2006-09-19 Procter & Gamble Company Controlled availability of formulation components, compositions and laundry methods employing same
US6903060B1 (en) 1999-08-27 2005-06-07 Procter & Gamble Company Stable formulation components, compositions and laundry methods employing same
US6825160B1 (en) 1999-08-27 2004-11-30 Procter & Gamble Company Color safe laundry methods employing cationic formulation components
JP2003508586A (ja) * 1999-08-27 2003-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー 迅速に作用する処方成分、それらの成分を使用する組成物および洗濯方法
BR0014153A (pt) * 1999-08-27 2002-05-07 Procter & Gamble Componentes de intensificação de branqueamento, composições e métodos de lavagem
US7557076B2 (en) * 2002-06-06 2009-07-07 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
US7169744B2 (en) * 2002-06-06 2007-01-30 Procter & Gamble Company Organic catalyst with enhanced solubility
US20050113246A1 (en) * 2003-11-06 2005-05-26 The Procter & Gamble Company Process of producing an organic catalyst
AR051659A1 (es) * 2005-06-17 2007-01-31 Procter & Gamble Una composicion que comprende un catalizador organico con compatibilidada enzimatica mejorada

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2721215A (en) * 1952-06-12 1955-10-18 Hoffmann La Rache Inc Diphenylacetyl diamines
US2785200A (en) * 1953-06-08 1957-03-12 Abbott Lab Dichlorobenzoyl-ethylenediamine
US2721214A (en) * 1953-06-09 1955-10-18 Parke Davis & Co Process for producing acylamido diols
US3576868A (en) * 1966-06-03 1971-04-27 Hoffmann La Roche Benzoyl amino ethyl aniline derivatives
US3501460A (en) * 1966-06-03 1970-03-17 Hoffmann La Roche Dehydration process for forming benzodiazepines
US3577557A (en) * 1966-12-09 1971-05-04 Sandoz Ag Benzo(1,5)diazocinones
US3723414A (en) * 1970-02-13 1973-03-27 Schering Corp 1-polyfluoroalkyl benzodiazepines
DE2166116A1 (de) * 1970-04-24 1973-02-15 Teikoku Hormone Mfg Co Ltd Verfahren zur herstellung von n-(dialkylaminoalkylen)-2-alkoxy(oder -alkenyloxy)4-amino-5-halogenbenzamiden
DK137857B (da) * 1970-09-03 1978-05-22 Takeda Chemical Industries Ltd Analogifremgangsmåde til fremstilling af 2-amino-1,5-benzodiazocinderivater eller farmaceutisk acceptable salte deraf.
JPS4728284Y1 (no) * 1970-09-14 1972-08-26
US4021224A (en) * 1971-12-09 1977-05-03 Stauffer Chemical Company Herbicide compositions
DE2265370C2 (de) * 1972-05-03 1982-12-02 Kali-Chemie Ag, 3000 Hannover 6-Phenyl-1,2,3,4-tetrahydro-1,5-benzodiazocinderivate
US3975443A (en) * 1972-06-06 1976-08-17 Allen & Hanburys Limited 1-(3,4-dichlorobenzamidomethyl)-cyclohexyldimethylamine
GB1374366A (en) * 1972-07-21 1974-11-20 Science Union & Cie Propanol derivatives and a process for their preparation
US3957870A (en) * 1973-07-19 1976-05-18 Imperial Chemical Industries Limited Organic compounds

Also Published As

Publication number Publication date
US4243585A (en) 1981-01-06
AT327919B (de) 1976-02-25
US3998809A (en) 1976-12-21
CA1020570A (en) 1977-11-08
DK147050B (da) 1984-03-26
IL47693A (en) 1978-07-31
CH620423A5 (no) 1980-11-28
DE2265370C2 (de) 1982-12-02
FR2183735A1 (no) 1973-12-21
IL47693A0 (en) 1975-10-15
GB1429666A (en) 1976-03-24
NL179111C (nl) 1986-07-16
GB1429665A (en) 1976-03-24
US4216167A (en) 1980-08-05
DK147050C (da) 1984-09-03
JPS5387385A (en) 1978-08-01
IL42158A (en) 1978-07-31
ES414279A1 (es) 1976-05-01
DE2221558C2 (de) 1982-12-02
JPS4941389A (no) 1974-04-18
ZA733013B (en) 1974-08-28
JPS5387333A (en) 1978-08-01
NO144386C (no) 1981-08-19
GB1429667A (en) 1976-03-24
NO145761C (no) 1982-05-26
NO751349L (no) 1973-11-06
IL48141A0 (en) 1975-11-25
FR2248278A1 (no) 1975-05-16
DK144969C (da) 1982-12-06
NL7305570A (no) 1973-11-06
CA984388A (en) 1976-02-24
NO142866B (no) 1980-07-28
US4098786A (en) 1978-07-04
SE422460B (sv) 1982-03-08
SU625607A3 (ru) 1978-09-25
AU5510173A (en) 1974-11-07
NO142476C (no) 1980-08-27
US4096141A (en) 1978-06-20
ATA143875A (de) 1975-05-15
ATA389973A (de) 1975-05-15
AT327920B (de) 1976-02-25
FR2296616A1 (fr) 1976-07-30
CH605834A5 (no) 1978-10-13
NO145761B (no) 1982-02-15
DK223077A (da) 1977-05-20
FR2183735B1 (no) 1976-09-03
NO144386B (no) 1981-05-11
NO793013L (no) 1973-11-06
NO761580L (no) 1973-11-06
IL42158A0 (en) 1973-07-30
NO780402L (no) 1973-11-06
AT327927B (de) 1976-02-25
DK144969B (da) 1982-07-19
NO144885B (no) 1981-08-24
US4595531A (en) 1986-06-17
DE2221558A1 (de) 1973-11-15
FR2248278B1 (no) 1977-11-04
NO142476B (no) 1980-05-19
JPS5813535B2 (ja) 1983-03-14
SE7614681L (sv) 1976-12-29
SE7614680L (sv) 1976-12-29
NO142866C (no) 1980-11-05
SU526290A3 (ru) 1976-08-25
DD105222A5 (no) 1974-04-12
FR2296616B1 (no) 1979-04-20
BE799001A (fr) 1973-08-31
NO143347B (no) 1980-10-13
IL48141A (en) 1978-07-31
DE2265371C3 (de) 1980-12-11
CH611609A5 (no) 1979-06-15
NO793012L (no) 1973-11-06
DE2265371B2 (de) 1980-04-17
ATA389873A (de) 1975-05-15
JPS589101B2 (ja) 1983-02-18
JPS5541231B2 (no) 1980-10-22
DK222977A (da) 1977-05-20
NO144885C (no) 1981-12-02
CH611608A5 (no) 1979-06-15
CA1009232A (en) 1977-04-26
CH611607A5 (no) 1979-06-15
NO143347C (no) 1981-01-21

Similar Documents

Publication Publication Date Title
SE409709B (sv) Forfarande for framstellning av 1,4-bensodiozepinderivat
US3635982A (en) Amino-substituted-quinoxalinyloxazolidines and -oxazines
SU1160935A3 (ru) Способ получени производных бензазепина или их кислотно-аддитивных солей с неорганическими кислотами
SU1331426A3 (ru) Способ получени производных карбостирила
SU997606A3 (ru) Способ получени производных простых ариловых эфиров или их фармацевтически приемлемых солей (его варианты)
DK156717B (da) Analogifremgangsmaade til fremstilling af indomethacinderivater
US20110003878A1 (en) Novel derivatives of phthalimide as histone deacetylase inhibitors
US3939161A (en) 1,3-Dimethyl- 1H-pyrazolo(4,3-D) pyrimidine-7 (6H)-ones
DE69625176T2 (de) Camptothecin-derivate und verfahren zu ihrer herstellung
US4013665A (en) Antiviral, substituted 1,3-dimethyl-1h-pyrazolo(3,4b)quinolines
FI59991B (fi) Foerfarande foer framstaellning av 2-arylamino-2-imidazolin-derivat och deras salter
Rajopadhye et al. Potential anticonvulsants. VII. Synthesis of 5′‐methylspiro [3H‐indole‐3, 2′‐thiazolidine]‐2, 4′(1H)‐diones
PL91728B1 (no)
US4140785A (en) N-(benzothienopyrazol)amide antirhinoviral agents
US4760062A (en) Pharmaceutical compositions of N-heterocyclic benzenesulfonamides and their use
US3008969A (en) 4-substituted-7-carboalkoxyamino-coumarins
US3748327A (en) Basically substituted 4(3h)-quinazolinone derivatives
US3830817A (en) 1-aziridinylcarbonyl-quinoline-carboxylic acid derivatives
SE503227C2 (sv) Substituerade styrenderivat, förfarande för framställning av dessa samt farmaceutiska kompositioner innehållande desamma
Greenwood et al. 2-Aryloxymethyl-2, 3, 5, 6-tetrahydro-1, 4-oxazines, a new class of antidepressants
HU197746B (en) Process for producing xantin derivatives and pharmaceutical compositions containing them
AU597083B2 (en) 4-nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties
US4073908A (en) 8-Amino-theophylline derivatives and therapeutic applications thereof
SU566521A3 (ru) Способ получени лактамов
US3976651A (en) 7-Hydroxy-benzo[ij]quinolizine-2-carboxylic acids, intermediates, and a method for their production